A comprehensive collection of the most recent knowledge on the
biological bases of various kinds of epilepsies and modern clinical
approaches to their treatment. Epilepsy affects about 0.5-1% of the
world's population (about 50,000,000 individuals) and the main goal of
its treatment is to eliminate seizures without creating side effects.
Despite numerous advances in the treatment of epilepsy and the approval
of several new antiepileptic drugs, about 30% of patients continue to
experience recurrent seizures which are medically, physically, and/or
socially disabling. The editor of this volume hopes that by bridging the
gap between the fundamental biology of epilepsy and its clinical
implications he might spur further research and treatment options.